Alfred H.J. Kim

机构：Washington University in St. Louis · ORCID：0000-0003-4074-0516

发表论文 153 篇 · 总被引 5718 次 · h-index 34

代表论文

• Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial (2025 · The Lancet Infectious Diseases · 被引 24)
• Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease (2024 · Annals of the Rheumatic Diseases · 被引 24)
• OMERACT systemic lupus erythematosus domain survey (2024 · Seminars in Arthritis and Rheumatism · 被引 9)
• The National Academies’ 2024 Diagnostic Criteria for Long COVID : Concerns That Could Affect the Rheumatology Community (2025 · Arthritis & Rheumatology · 被引 5)
• Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics (2025 · Lara D. Veeken · 被引 4)
• A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases (2025 · ACR Open Rheumatology · 被引 3)